/
BNTX
$90.58-$2.27 (-2.44%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$22.9B
253M shares
52-week range
$79.52 – $124.00
25% from low
Exchange
NASDAQ
ADRC
Change$-249.63
BioNTech SE American Depositary Share
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
www.biontech.de- Employees
- 7,807
- IPO / List date
- Oct 10, 2019
Held by traders on TradeandTell
No one on the platform currently holds BNTX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2025-12-31 | 4,927 | $469.1K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BNTX yet.
